| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.92 | 0.004 | 0.973 | Angiogenesis inhibitor | 0.938 0.004 CHEMBL377300 0.973 0.003 CHEMBL3527569 0.914 0.004 CHEMBL3526621 0.933 0.004 CHEMBL3526252 0.967 0.004 CHEMBL3526270 0.884 0.005 CHEMBL3526543 0.962 0.004 CHEMBL3527397 | CHEMBL3527569 | |
| 0.587 | 0.008 | 0.864 | Growth factor antagonist | 0.804 0.005 CHEMBL377300 0.812 0.005 CHEMBL3527569 0.732 0.005 CHEMBL3526621 0.864 0.004 CHEMBL3526252 0.708 0.005 CHEMBL3526270 0.66 0.005 CHEMBL3526543 0.644 0.005 CHEMBL3527397 | CHEMBL3526252 | |
| 0.497 | 0.009 | 0.733 | Vascular endothelial growth factor antagonist | 0.727 0.005 CHEMBL377300 0.717 0.005 CHEMBL3527569 0.653 0.005 CHEMBL3526621 0.733 0.005 CHEMBL3526252 0.606 0.005 CHEMBL3526270 0.555 0.006 CHEMBL3526543 0.518 0.008 CHEMBL3527397 | CHEMBL3526252 | |
| 0.482 | 0.009 | 0.715 | Vascular endothelial growth factor 2 antagonist | 0.709 0.005 CHEMBL377300 0.654 0.005 CHEMBL3527569 0.636 0.005 CHEMBL3526621 0.715 0.005 CHEMBL3526252 0.533 0.007 CHEMBL3526270 0.541 0.006 CHEMBL3526543 0.444 0.01 CHEMBL3527397 | CHEMBL3526252 | |
| 0.379 | 0.005 | 0.674 | Fibroblast growth factor 1 antagonist | 0.498 0.004 CHEMBL377300 0.674 0.004 CHEMBL3527569 0.441 0.004 CHEMBL3526621 0.489 0.004 CHEMBL3526252 0.623 0.004 CHEMBL3526270 0.36 0.005 CHEMBL3526543 0.564 0.004 CHEMBL3527397 | CHEMBL3527569 | |
| 0.32 | 0.004 | 0.635 | Hepatocyte growth factor antagonist | 0.545 0.004 CHEMBL377300 0.343 0.004 CHEMBL3527569 0.45 0.004 CHEMBL3526621 0.635 0.003 CHEMBL3526252 0.277 0.005 CHEMBL3526270 0.4 0.004 CHEMBL3526543 0.261 0.005 CHEMBL3527397 | CHEMBL3526252 | |
| 0.424 | 0.125 | 0.424 | Antiinflammatory | 0.383 0.149 CHEMBL377300 0.375 0.155 CHEMBL3527569 0.382 0.15 CHEMBL3526621 0.393 0.143 CHEMBL3526252 0.385 0.148 CHEMBL3526270 0.352 0.171 CHEMBL3526543 0.358 0.166 CHEMBL3527397 | ||
| 0.275 | 0.023 | 0.415 | Vascular endothelial growth factor 3 antagonist | 0.411 0.009 CHEMBL377300 0.216 0.036 CHEMBL3527569 0.316 0.016 CHEMBL3526621 0.415 0.009 CHEMBL3526252 0.143 0.072 CHEMBL3526270 0.347 0.014 CHEMBL3526543 0.164 0.058 CHEMBL3527397 | CHEMBL3526252 | |
| 0.364 | 0.112 | 0.456 | Cyclophilin D inhibitor | 0.313 0.151 CHEMBL377300 0.239 0.226 CHEMBL3527569 0.456 0.065 CHEMBL3526621 0.402 0.09 CHEMBL3526270 0.344 0.126 CHEMBL3526543 0.301 0.162 CHEMBL3527397 | CHEMBL3526621 | |
| 0.173 | 0.016 | 0.463 | Alcohol dehydrogenase inhibitor | 0.408 0.004 CHEMBL377300 0.108 0.044 CHEMBL3527569 0.29 0.005 CHEMBL3526621 0.275 0.006 CHEMBL3526252 0.089 0.065 CHEMBL3526270 0.463 0.003 CHEMBL3526543 0.144 0.022 CHEMBL3527397 | CHEMBL3526543 | |
| 0.134 | 0.019 | 0.187 | Fibroblast growth factor 3 antagonist | 0.187 0.008 CHEMBL377300 0.133 0.019 CHEMBL3526621 0.151 0.014 CHEMBL3526252 0.081 0.049 CHEMBL3526543 | CHEMBL377300 | |
| 0.163 | 0.055 | 0.293 | RET inhibitor | 0.242 0.033 CHEMBL377300 0.105 0.091 CHEMBL3527569 0.129 0.073 CHEMBL3526621 0.293 0.024 CHEMBL3526252 0.114 0.084 CHEMBL3526543 | CHEMBL3526252 | |
| 0.102 | 0.009 | 0.168 | Proto-oncogene tyrosine-protein kinase Met inhibitor | 0.145 0.005 CHEMBL377300 0.097 0.01 CHEMBL3527569 0.127 0.005 CHEMBL3526621 0.168 0.005 CHEMBL3526252 0.083 0.015 CHEMBL3526270 0.112 0.007 CHEMBL3526543 0.074 0.019 CHEMBL3527397 | CHEMBL3526252 | |
| 0.189 | 0.102 | 0.266 | ErbB-1 antagonist | 0.266 0.044 CHEMBL377300 0.193 0.097 CHEMBL3527569 0.256 0.049 CHEMBL3526621 0.237 0.059 CHEMBL3526252 0.183 0.111 CHEMBL3526270 0.237 0.058 CHEMBL3526543 0.172 0.129 CHEMBL3527397 | CHEMBL377300 | |
| 0.271 | 0.2 | 0.557 | 5 Hydroxytryptamine release inhibitor | 0.377 0.094 CHEMBL377300 0.281 0.188 CHEMBL3526621 0.557 0.018 CHEMBL3526543 | CHEMBL3526543 | |
| 0.166 | 0.11 | 0.212 | Platelet aggregation inhibitor | 0.195 0.084 CHEMBL377300 0.145 0.134 CHEMBL3526621 0.212 0.073 CHEMBL3526252 0.146 0.134 CHEMBL3526543 | CHEMBL3526252 | |
| 0.095 | 0.044 | 0.137 | AXL receptor tyrosine kinase inhibitor | 0.131 0.023 CHEMBL377300 0.076 0.067 CHEMBL3527569 0.095 0.044 CHEMBL3526621 0.137 0.021 CHEMBL3526252 0.094 0.045 CHEMBL3526543 | CHEMBL3526252 | |
| 0.082 | 0.033 | 0.135 | Transforming growth factor antagonist | 0.098 0.022 CHEMBL377300 0.083 0.032 CHEMBL3526621 0.135 0.008 CHEMBL3526252 0.071 0.046 CHEMBL3526543 | CHEMBL3526252 | |
| 0.142 | 0.094 | 0.26 | Tyrosine kinase inhibitor | 0.215 0.064 CHEMBL377300 0.189 0.073 CHEMBL3526621 0.26 0.051 CHEMBL3526252 0.146 0.092 CHEMBL3526543 | CHEMBL3526252 | |
| 0.096 | 0.063 | 0.181 | Platelet activating factor alpha antagonist | 0.162 0.026 CHEMBL377300 0.132 0.038 CHEMBL3526621 0.181 0.02 CHEMBL3526252 0.12 0.044 CHEMBL3526543 | CHEMBL3526252 | |
| 0.072 | 0.04 | 0.208 | Fibroblast growth factor 2 antagonist | 0.208 0.005 CHEMBL377300 0.176 0.007 CHEMBL3527569 0.178 0.007 CHEMBL3526621 0.121 0.017 CHEMBL3526252 0.142 0.012 CHEMBL3526270 0.102 0.023 CHEMBL3526543 0.075 0.037 CHEMBL3527397 | CHEMBL377300 | |
| 0.075 | 0.053 | 0.136 | ErbB-2 antagonist | 0.126 0.025 CHEMBL377300 0.075 0.052 CHEMBL3527569 0.104 0.034 CHEMBL3526621 0.136 0.023 CHEMBL3526252 0.088 0.041 CHEMBL3526543 | CHEMBL3526252 | |
| 0.106 | 0.098 | 0.215 | Phosphodiesterase inhibitor | 0.215 0.03 CHEMBL377300 0.207 0.033 CHEMBL3526621 0.215 0.03 CHEMBL3526252 0.166 0.049 CHEMBL3526543 | CHEMBL3526252 | |
| 0.011 | 0.009 | 0.013 | Glucose-dependent insulinotropic receptor antagonist | 0.013 0.006 CHEMBL377300 0.012 0.009 CHEMBL3527569 0.012 0.008 CHEMBL3526621 0.013 0.006 CHEMBL3526252 0.012 0.008 CHEMBL3526543 | CHEMBL3526252 | |
| 0.039 | 0.038 | 0.091 | Phosphodiesterase 10A inhibitor | 0.091 0.011 CHEMBL377300 0.082 0.013 CHEMBL3526621 0.077 0.014 CHEMBL3526252 0.059 0.021 CHEMBL3526543 | CHEMBL377300 | |
| 0.039 | 0.038 | 0.091 | Phosphodiesterase X inhibitor | 0.091 0.011 CHEMBL377300 0.082 0.013 CHEMBL3526621 0.077 0.014 CHEMBL3526252 0.059 0.021 CHEMBL3526543 | CHEMBL377300 | |
| 0.09 | 0.088 | 0.204 | Platelet activating factor antagonist | 0.153 0.043 CHEMBL377300 0.114 0.067 CHEMBL3526621 0.204 0.025 CHEMBL3526252 0.093 0.085 CHEMBL3526543 | CHEMBL3526252 | |
| 0.077 | 0.077 | 0.087 | Transforming growth factor beta 3 antagonist | 0.082 0.058 CHEMBL377300 0.087 0.045 CHEMBL3526252 | CHEMBL3526252 | |
| 0.01 | 0.018 | 0.017 | 5 Lipoxygenase activating protein inhibitor | 0.016 0.007 CHEMBL377300 0.017 0.005 CHEMBL3526621 0.013 0.01 CHEMBL3526252 0.015 0.008 CHEMBL3526543 | CHEMBL3526621 | |
| 0.007 | 0.021 | 0.012 | Egl nine homolog 2 inhibitor | 0.012 0.009 CHEMBL3526252 0.011 0.009 CHEMBL3526543 | CHEMBL3526252 | |
| 0.017 | 0.034 | 0.02 | Histone-lysine N-methyltransferase EZH2 inhibitor | 0.02 0.018 CHEMBL377300 0.02 0.015 CHEMBL3526252 | CHEMBL3526252 | |
| 0.091 | 0.113 | 0.138 | Epidermal growth factor receptor kinase inhibitor | 0.131 0.062 CHEMBL377300 0.111 0.083 CHEMBL3526621 0.138 0.057 CHEMBL3526252 0.105 0.091 CHEMBL3526543 | CHEMBL3526252 | |
| 0.065 | 0.105 | 0.136 | Vascular endothelial growth factor 1 antagonist | 0.134 0.047 CHEMBL377300 0.136 0.046 CHEMBL3526252 | CHEMBL3526252 | |
| 0.071 | 0.119 | 0.189 | MAP kinase kinase 1 inhibitor | 0.189 0.006 CHEMBL377300 0.181 0.008 CHEMBL3526621 0.16 0.013 CHEMBL3526543 | CHEMBL377300 | |
| 0.029 | 0.09 | 0.075 | Phosphodiesterase 2A inhibitor | 0.068 0.019 CHEMBL377300 0.075 0.015 CHEMBL3526621 0.046 0.04 CHEMBL3526252 0.049 0.035 CHEMBL3526543 | CHEMBL3526621 | |
| 0.032 | 0.094 | 0.084 | Phosphodiesterase II inhibitor | 0.076 0.02 CHEMBL377300 0.084 0.016 CHEMBL3526621 0.054 0.041 CHEMBL3526252 0.057 0.036 CHEMBL3526543 | CHEMBL3526621 | |
| 0.05 | 0.115 | 0.131 | Platelet activating factor beta antagonist | 0.117 0.052 CHEMBL377300 0.131 0.045 CHEMBL3526252 | CHEMBL3526252 | |
| 0.042 | 0.111 | 0.059 | Neuraminidase (influenza) inhibitor | 0.059 0.057 CHEMBL3527397 | CHEMBL3527397 | |
| 0.068 | 0.153 | 0.295 | MAP kinase kinase inhibitor | 0.295 0.009 CHEMBL377300 0.262 0.013 CHEMBL3526621 0.224 0.021 CHEMBL3526543 | CHEMBL377300 | |
| 0.043 | 0.134 | 0.083 | Proto-oncogene tyrosine-protein kinase Kit inhibitor | 0.083 0.07 CHEMBL3526252 | CHEMBL3526252 | |
| 0.101 | 0.199 | 0.131 | Death-associated protein kinase 1 inhibitor | 0.119 0.116 CHEMBL377300 0.131 0.078 CHEMBL3526252 | CHEMBL3526252 | |
| 0.153 | 0.272 | 0.293 | Toll-Like receptor agonist | 0.293 0.115 CHEMBL3526621 | CHEMBL3526621 | |
| 0.008 | 0.143 | 0.033 | G protein-coupled receptor agonist | 0.033 0.032 CHEMBL3526621 | CHEMBL3526621 | |
| 0.048 | 0.194 | 0.098 | Insulin receptor antagonist | 0.098 0.064 CHEMBL377300 | CHEMBL377300 | |
| 0.05 | 0.205 | 0.139 | Lck kinase inhibitor | 0.139 0.072 CHEMBL3526252 | CHEMBL3526252 | |
| 0.114 | 0.269 | 0.171 | MAP-kinase-activated kinase 5 inhibitor | 0.171 0.146 CHEMBL3526252 | CHEMBL3526252 | |
| 0.139 | 0.299 | 0.295 | Toll-Like receptor 7 agonist | 0.295 0.113 CHEMBL3526621 | CHEMBL3526621 | |
| 0.015 | 0.204 | 0.055 | Cholecystokinin B agonist | 0.055 0.013 CHEMBL3527569 0.052 0.015 CHEMBL3526270 0.053 0.014 CHEMBL3527397 | CHEMBL3527569 | |
| 0.025 | 0.221 | 0.07 | Platelet growth factor antagonist | 0.07 0.069 CHEMBL3526252 | CHEMBL3526252 | |
| 0.005 | 0.265 | 0.025 | Cholecystokinin A agonist | 0.025 0.007 CHEMBL3527569 0.021 0.008 CHEMBL3526270 0.023 0.007 CHEMBL3527397 | CHEMBL3527569 | |
| 0.004 | 0.272 | 0.028 | Cholecystokinin agonist | 0.028 0.01 CHEMBL3527569 0.021 0.012 CHEMBL3526270 0.024 0.011 CHEMBL3527397 | CHEMBL3527569 | |
| 0.042 | 0.342 | 0.136 | Angiogenesis stimulant | 0.136 0.131 CHEMBL3526270 | CHEMBL3526270 | |
| 0.011 | 0.324 | 0.085 | Selectin antagonist | 0.064 0.046 CHEMBL3527569 0.085 0.034 CHEMBL3526270 0.071 0.042 CHEMBL3527397 | CHEMBL3526270 | |
| 0.02 | 0.345 | 0.084 | Factor IXa inhibitor | 0.053 0.034 CHEMBL3527569 0.06 0.026 CHEMBL3526270 0.084 0.014 CHEMBL3527397 | CHEMBL3527397 | |
| 0.127 | 0.476 | 0.47 | Calcium channel L-type activator | 0.47 0.041 CHEMBL3526621 0.397 0.083 CHEMBL3526270 | CHEMBL3526621 | |
| 0.073 | 0.471 | 0.395 | Histamine release inhibitor | 0.395 0.078 CHEMBL3526543 0.34 0.104 CHEMBL3527397 | CHEMBL3526543 | |
| 0.024 | 0.491 | 0.152 | Anticoagulant | 0.126 0.105 CHEMBL3527569 0.125 0.106 CHEMBL3526270 0.152 0.079 CHEMBL3527397 | CHEMBL3527397 | |
| 0.014 | 0.512 | 0.035 | Calcium-independent phospholipase A2 inhibitor | 0.035 0.021 CHEMBL3526252 | CHEMBL3526252 | |
| 0.016 | 0.692 | 0.163 | Hemostatic | 0.163 0.054 CHEMBL3527397 | CHEMBL3527397 | |
| 0.005 | 0.794 | 0.161 | CDC25A inhibitor | 0.158 0.011 CHEMBL3527569 0.161 0.011 CHEMBL3526270 0.154 0.012 CHEMBL3527397 | CHEMBL3526270 | |
| 0.006 | 0.846 | 0.365 | Dual specificity phosphatase 3 inhibitor | 0.358 0.019 CHEMBL3527569 0.36 0.019 CHEMBL3526270 0.365 0.018 CHEMBL3527397 | CHEMBL3527397 | |
| 0.005 | 0.866 | 0.122 | Protein-tyrosine phosphatase inhibitor | 0.122 0.111 CHEMBL3527397 | CHEMBL3527397 | |
| 0.007 | 0.884 | 0.368 | Dual specificity phosphatase inhibitor | 0.358 0.02 CHEMBL3527569 0.358 0.02 CHEMBL3526270 0.368 0.018 CHEMBL3527397 | CHEMBL3527397 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |